Con

Bertha Madras, PhD, Professor of Psychobiology in the Department of Psychiatry at Harvard Medical School, stated the following in her Apr. 29, 2016 article titled "5 Reasons Marijuana Is Not Medicine," available on the Washington Post website:

“While the FDA is not averse to approving cannabinoids as medicines and has approved two cannabinoid medications, the decision to keep marijuana in Schedule I was reaffirmed in a 2015 federal court ruling. That ruling was correct…

Marijuana fails to meet any of [the] five criteria for accepted medical use in the United States. At present, it belongs in Schedule I…

The process for marijuana research could be streamlined by Drug Enforcement Administration oversight and expansion of marijuana production, and a special sub-category of Schedule I could further reduce paperwork. But moving marijuana to Schedule II ‘to promote research’ is conceivably unethical, as marijuana would then be designated a safe and effective medicine in the absence of high-quality evidence.”

Apr. 29, 2016